Laurion Capital Management LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Laurion Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$65.78 - $105.02 $649,380 - $1.04 Million	-9,872 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $632,499 - $905,756	9,872 New	9,872 $675,000
Q3 2020 Nov 13, 2020	SELL	$59.04 - $77.95 $350,461 - $462,711	-5,936 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $4.95 Million - $12.7 Million	-170,464 Reduced 96.63%	5,936 $434,000
Q1 2020 May 14, 2020	BUY	$27.51 - $57.29 $4.85 Million - $10.1 Million	176,400 New	176,400 $6 Million
Q3 2019 Nov 13, 2019	SELL	$37.38 - $49.47 $3.17 Million - $4.19 Million	-84,713 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$39.79 - $67.01 $3.37 Million - $5.68 Million	84,713 New	84,713 $3.71 Million
Q1 2019 May 08, 2019	SELL	$34.52 - $53.29 $5.28 Million - $8.15 Million	-152,946 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $4.55 Million - $6.56 Million	152,946 New	152,946 $5.66 Million
Q2 2018 Aug 13, 2018	SELL	$23.62 - $42.29 $899,827 - $1.61 Million	-38,096 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$22.49 - $34.56 $856,779 - $1.32 Million	38,096 New	38,096 $981,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.